Optimization of a Dibenzodiazepine Hit to a Potent and Selective Allosteric PAK1 Inhibitor

被引:82
作者
Karpov, Alexei S. [1 ]
Amiri, Payman [2 ]
Bellamacina, Cornelia [2 ]
Bellance, Marie-Helene [1 ]
Breitenstein, Werner [1 ]
Daniel, Dylan [2 ]
Denay, Regis [1 ]
Fabbro, Doriano [1 ]
Fernandez, Cesar [1 ]
Galuba, Inga [1 ]
Guerro-Lagasse, Stephanie [1 ]
Gutmann, Sascha [1 ]
Hinh, Linda [2 ]
Jahnke, Wolfgang [1 ]
Klopp, Julia [1 ]
Lai, Albert [2 ]
Lindvall, Mika K. [2 ]
Ma, Sylvia [2 ]
Moebitz, Henrik [1 ]
Pecchi, Sabina [2 ]
Rummel, Gabriele [1 ]
Shoemaker, Kevin [2 ]
Trappe, Joerg [1 ]
Voliva, Charles [2 ]
Cowan-Jacob, Sandra W. [1 ]
Marzinzik, Andreas L. [1 ]
机构
[1] Novartis Inst BioMed Res, CH-4056 Basel, Switzerland
[2] Novartis Inst BioMed Res, Emeryville, CA 94608 USA
关键词
PAK1; p21 activated kinase; allosteric inhibitor; dibenzodiazepine; tool compound; SMALL-MOLECULE INHIBITOR; FRAGILE-X-SYNDROME; P21-ACTIVATED KINASES; AUTOPHOSPHORYLATION; ACTIVATION; DISCOVERY; MECHANISM; CANCER; MICE;
D O I
10.1021/acsmedchemlett.5b00102
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The discovery of inhibitors targeting novel allosteric kinase sites is very challenging. Such compounds, however, once identified could offer exquisite levels of selectivity across the kinome. Herein we report our structure-based optimization strategy of a dibenzodiazepine hit 1, discovered in a fragment-based screen, yielding highly potent and selective inhibitors of PAK1 such as 2 and 3. Compound 2 was cocrystallized with PAK1 to confirm binding to an allosteric site and to reveal novel key interactions. Compound 3 modulated PAK1 at the cellular level and due to its selectivity enabled valuable research to interrogate biological functions of the PAK1 kinase.
引用
收藏
页码:776 / 781
页数:6
相关论文
共 27 条
[1]   The mechanism of PAK activation - Autophosphorylation events in both regulatory and kinase domains control activity [J].
Chong, C ;
Tan, L ;
Lim, L ;
Manser, E .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (20) :17347-17353
[2]  
Coleman Natalia, 2012, Cell Logist, V2, P132
[3]   Novel approaches for targeting kinases: allosteric inhibition, allosteric activation and pseudokinases [J].
Cowan-Jacob, Sandra W. ;
Jahnke, Wolfgang ;
Knapp, Stefan .
FUTURE MEDICINAL CHEMISTRY, 2014, 6 (05) :541-561
[4]   An isoform-selective, small-molecule inhibitor targets the autoregulatory mechanism of p21-activated kinase [J].
Deacon, Sean W. ;
Beeser, Alexander ;
Fukui, Jami A. ;
Rennefahrt, Ulrike E. E. ;
Myers, Cynthia ;
Chernoff, Jonathan ;
Peterson, Jeffrey R. .
CHEMISTRY & BIOLOGY, 2008, 15 (04) :322-331
[5]   Discovery of a benzo[e]pyrimido-[5,4-b][1,4]diazepin-6(11H)-one as a Potent and Selective Inhibitor of Big MAP Kinase 1 [J].
Deng, Xianming ;
Yang, Qingkai ;
Kwiatkowski, Nicholas ;
Sim, Taebo ;
McDermott, Ultan ;
Settleman, Jeffrey E. ;
Lee, Jiing-Dwan ;
Gray, Nathanael S. .
ACS MEDICINAL CHEMISTRY LETTERS, 2011, 2 (03) :195-200
[6]  
Dolan BM, 2013, P NATL ACAD SCI USA, V110, P5671, DOI [10.1073/pnas.1219383110, 10.1073/pnas.1219353110]
[7]   UnPAKing the class differences among p21-activated kinases [J].
Eswaran, Jeyanthy ;
Soundararajan, Meera ;
Kumar, Rakesh ;
Knapp, Stefan .
TRENDS IN BIOCHEMICAL SCIENCES, 2008, 33 (08) :394-403
[8]   Molecular Pathways: Targeting P21-Activated Kinase 1 Signaling in Cancer-Opportunities, Challenges, and Limitations [J].
Eswaran, Jeyanthy ;
Li, Da-Qiang ;
Shah, Anil ;
Kumar, Rakesh .
CLINICAL CANCER RESEARCH, 2012, 18 (14) :3743-3749
[9]   Discovery of a Type III Inhibitor of LIM Kinase 2 That Binds in a DFG-Out Conformation [J].
Goodwin, Nicole C. ;
Cianchetta, Giovanni ;
Burgoon, Hugh A. ;
Healy, Jason ;
Mabon, Ross ;
Strobel, Eric D. ;
Allen, Jason ;
Wang, Shuli ;
Hamman, Brian D. ;
Rawlins, David B. .
ACS MEDICINAL CHEMISTRY LETTERS, 2015, 6 (01) :53-57
[10]   Inhibition of p21-activated kinase rescues symptoms of fragile X syndrome in mice [J].
Hayashi, Mansuo L. ;
Rao, B. S. Shankaranarayana ;
Seo, Jin-Soo ;
Choi, Han-Saem ;
Dolan, Bridget M. ;
Choi, Se-Young ;
Chattarji, Sumantra ;
Tonegawa, Susumu .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (27) :11489-11494